Kiniksa Pharmaceuticals International KNSA
NASDAQ KNSA
$75.73 -0.37 (-0.49%)
At close: Sep 29, 2026 · 4:00 PM EDT

Kiniksa Pharmaceuticals International (KNSA) Enterprise Value (2018 - 2026)

Updated

Kiniksa Pharmaceuticals International (KNSA) posted Enterprise Value of $9.45 billion for Q2 2026, up 149.3% from $3.79 billion a year earlier and up 36.4% from the prior quarter.

Analysis

Kiniksa Pharmaceuticals International (KNSA) Enterprise Value (2018 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Enterprise Value at Kiniksa Pharmaceuticals International was $8.72 billion, up 129.9% year-over-year; for FY2025, it came in at $5.89 billion, up 123.9% from FY2024.

  • Annual Enterprise Value has increased for four consecutive years, with a five-year compound annual growth rate of 23.1% (FY2020 to FY2025).
  • In prior years, Kiniksa Pharmaceuticals International's Enterprise Value was $2.63 billion in FY2024 (+16.0%), $2.27 billion in FY2023 (+19.5%), $1.9 billion in FY2022 (+31.5%) and $1.44 billion in FY2021 (-30.8%).
  • The Q2 2026 figure stands as the highest quarterly Enterprise Value in data going back to Q2 2018.
  • On a year-over-year basis, Enterprise Value has increased in each of the last 16 quarters, with growth averaging 76.4% over the last eight quarters.
  • The strongest year-over-year quarter for Enterprise Value in the past five years was Q2 2026, with growth of 149.3%; the weakest was Q1 2022, with a decline of 45.6%.
  • According to Business Quant data, Enterprise Value for the three prior quarters was $6.93 billion (Q1 2026), $5.89 billion (Q4 2025) and $5.53 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Kiniksa Pharmaceuticals International 11.87 Bn 10.61 Bn 220.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.45 Bn
Mar 31, 2026 6.93 Bn
Dec 31, 2025 5.89 Bn
Sep 30, 2025 5.53 Bn
Jun 30, 2025 3.79 Bn
Mar 31, 2025 2.97 Bn
Dec 31, 2024 2.63 Bn
Sep 30, 2024 3.38 Bn
Jun 30, 2024 2.44 Bn
Mar 31, 2024 2.50 Bn
Dec 31, 2023 2.27 Bn
Sep 30, 2023 2.24 Bn
Jun 30, 2023 1.79 Bn
Mar 31, 2023 1.32 Bn
Dec 31, 2022 1.90 Bn
Sep 30, 2022 1.58 Bn
Jun 30, 2022 1.21 Bn
Mar 31, 2022 1.23 Bn
Dec 31, 2021 1.44 Bn
Sep 30, 2021 1.37 Bn
API Access

Kiniksa Pharmaceuticals International Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=KNSA&period=max&api_key=YOUR_API_KEY